Rare tumor platform trial for new therapies
Treatments studied
Part of Cancer clinical trials.
This trial is designed for people with rare types of cancer. It tests new therapies and technologies, and aims to find which ones work best for different tumors. You will need to provide a fresh tumor sample and blood sample for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have a confirmed cancer diagnosis.
- You are able to walk and take care of yourself (ECOG 0-2) and expected to live at least 12 weeks.
- You have cancer that can be measured or seen on scans.
- You are willing to provide a fresh tumor biopsy and blood sample if possible.
- You have no uncontrolled infections, serious heart problems, or recent major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized treatment made from your own immune cells (T-cells) that are modified to attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
This trial tests a personalized cell therapy that uses your own immune cells (T-cells) specially modified to target your tumor. It is for people with advanced solid tumors who have run out of standard treatment options.
This trial tests if growing a patient's tumor cells in the lab (organoids) and analyzing their genes can help doctors choose more effective treatments for rare cancers. You might be eligible if you have an advanced rare solid tumor and can provide fresh or stored tumor tissue for testing.
This study tests targeted drugs or immunotherapy based on the genetic features of your tumor. It may help people with rare, advanced cancers whose disease has progressed after standard treatment options.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
Hear when a new Rare Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.